• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性淋巴细胞为主型霍奇金淋巴瘤的组织病理学特征及其对预后的影响——德国霍奇金研究组(GHSG)的配对分析。

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).

机构信息

Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.

出版信息

Br J Haematol. 2014 Oct;167(2):238-42. doi: 10.1111/bjh.12997. Epub 2014 Jun 26.

DOI:10.1111/bjh.12997
PMID:24965443
Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity. We performed a matched-pair analysis to evaluate the prognostic impact of several histopathological features in this distinct Hodgkin lymphoma subtype. Lymph node samples of NLPHL patients were tested for CD15, IgD, phosphorylated STAT6, ICOS and Epstein-Barr virus status of the malignant lymphocyte-predominant cells as well as epithelioid cell clusters and activated T cells in the microenvironment. None of these features was associated with a particular clinical outcome. However, patients presenting with epithelioid cell clusters showed a non-significant trend towards a lower relapse rate, justifying further evaluation of this marker.

摘要

结节性淋巴细胞为主型霍奇金淋巴瘤(NLPHL)是一种罕见的淋巴瘤实体。我们进行了配对分析,以评估这种独特的霍奇金淋巴瘤亚型中几种组织病理学特征的预后影响。NLPHL 患者的淋巴结样本检测了恶性淋巴细胞为主细胞的 CD15、IgD、磷酸化 STAT6、ICOS 和 Epstein-Barr 病毒状态,以及微环境中的上皮样细胞簇和活化的 T 细胞。这些特征均与特定的临床结局无关。然而,表现为上皮样细胞簇的患者复发率较低,这一趋势虽无统计学意义,但仍值得进一步研究该标志物。

相似文献

1
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).结节性淋巴细胞为主型霍奇金淋巴瘤的组织病理学特征及其对预后的影响——德国霍奇金研究组(GHSG)的配对分析。
Br J Haematol. 2014 Oct;167(2):238-42. doi: 10.1111/bjh.12997. Epub 2014 Jun 26.
2
Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.结节性淋巴细胞为主型霍奇金淋巴瘤中具有滤泡辅助性 T 细胞表型的结节内活化细胞簇:来自芬兰的 32 例初步研究。
Hum Pathol. 2013 Sep;44(9):1737-46. doi: 10.1016/j.humpath.2013.02.010. Epub 2013 May 15.
3
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.医源性免疫缺陷相关经典型霍奇金淋巴瘤:10 例临床病理研究。
Am J Surg Pathol. 2013 Aug;37(8):1290-7. doi: 10.1097/PAS.0b013e31828e6564.
4
Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.结节性淋巴细胞为主型霍奇金淋巴瘤伴非典型 T 细胞:一种模仿外周 T 细胞淋巴瘤的形态学变异型。
Am J Surg Pathol. 2011 Nov;35(11):1666-78. doi: 10.1097/PAS.0b013e31822832de.
5
Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.结节性淋巴细胞为主型和经典霍奇金淋巴瘤-Epstein-Barr 病毒相关的复合淋巴瘤提示尽管存在克隆相关性,但发病机制不同。
Hum Pathol. 2013 Jul;44(7):1434-9. doi: 10.1016/j.humpath.2012.11.018. Epub 2013 Feb 18.
6
Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.经典型霍奇金淋巴瘤中程序性死亡-1+肿瘤浸润淋巴细胞增加,证实总生存期缩短。
Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19.
7
Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.结节性淋巴细胞为主型霍奇金淋巴瘤的免疫结构模式:病理及临床意义
Expert Rev Hematol. 2015 Apr;8(2):217-23. doi: 10.1586/17474086.2015.991388. Epub 2014 Dec 9.
8
Nodular lymphocyte-predominant hodgkin lymphoma.结节性淋巴细胞为主型霍奇金淋巴瘤
Semin Radiat Oncol. 2007 Jul;17(3):184-9. doi: 10.1016/j.semradonc.2007.02.004.
9
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).结节性淋巴细胞为主型霍奇金淋巴瘤中变异型组织学的预后影响:德国霍奇金研究组(GHSG)的报告。
Blood. 2013 Dec 19;122(26):4246-52; quiz 4292. doi: 10.1182/blood-2013-07-515825. Epub 2013 Oct 7.
10
Modern management of lymphocyte-predominant Hodgkin lymphoma.淋巴细胞为主型霍奇金淋巴瘤的现代治疗策略。
Br J Haematol. 2013 May;161(3):316-29. doi: 10.1111/bjh.12244. Epub 2013 Feb 8.

引用本文的文献

1
A Rare Manifestation of a Rare Disease: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Presenting As Paraneoplastic Aseptic Meningitis.一种罕见疾病的罕见表现:以副肿瘤性无菌性脑膜炎形式呈现的结节性淋巴细胞为主型霍奇金淋巴瘤
Cureus. 2025 Jun 18;17(6):e86327. doi: 10.7759/cureus.86327. eCollection 2025 Jun.
2
Histopathologic Features and Differential Diagnosis in Challenging Cases of Nodular Lymphocyte Predominant B-cell Lymphoma/Nodular Lymphocyte Predominant Hodgkin Lymphoma.结节性淋巴细胞为主型B细胞淋巴瘤/结节性淋巴细胞为主型霍奇金淋巴瘤疑难病例的组织病理学特征及鉴别诊断
J Clin Transl Pathol. 2024 Jun;4(2):61-69. doi: 10.14218/jctp.2024.00015.
3
The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
结节性淋巴细胞为主型霍奇金淋巴瘤的谱系:欧洲血液病理学协会第 20 次会议淋巴瘤研讨会报告。
Virchows Arch. 2023 Oct;483(4):451-463. doi: 10.1007/s00428-023-03554-1. Epub 2023 Aug 2.
4
Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?结节性淋巴细胞为主型霍奇金淋巴瘤的治疗:我们目前的状况如何?我们将何去何从?
Cancers (Basel). 2023 Jun 23;15(13):3310. doi: 10.3390/cancers15133310.
5
MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma.MEF2B是突出结节性淋巴细胞为主型霍奇金淋巴瘤中肿瘤性LP细胞的理想免疫组化标志物。
EJHaem. 2023 Apr 13;4(2):517-519. doi: 10.1002/jha2.690. eCollection 2023 May.
6
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion.结节性淋巴细胞为主型霍奇金淋巴瘤:文献复习与病例讨论。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221111767. doi: 10.1177/23247096221111767.
7
A Rare Case of Good Outcome of Hodgkin Lymphoma in a Patient with HIV on Antiretroviral Therapy (ART).抗逆转录病毒疗法(ART)下 HIV 感染者霍奇金淋巴瘤良好转归 1 例罕见报告
Am J Case Rep. 2022 May 15;23:e936267. doi: 10.12659/AJCR.936267.
8
Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation.具有高转化风险的结节性淋巴细胞为主型霍奇金淋巴瘤的进化克隆轨迹。
Haematologica. 2021 Oct 1;106(10):2654-2666. doi: 10.3324/haematol.2021.278427.
9
Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.低风险儿童结节性淋巴细胞为主型霍奇金淋巴瘤的组织学变异、IgD和CD30表达:儿童肿瘤学组报告
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26753. Epub 2017 Aug 12.
10
[Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].[结节性淋巴细胞为主型霍奇金淋巴瘤及相关病变的最新进展]
Pathologe. 2017 Feb;38(1):3-10. doi: 10.1007/s00292-016-0257-6.